The BMS was developed in collaboration with Log9 Materials and currently boasts 30 per cent localisation
The decision to expand into South India is a strategic move, driven by the region's rapid growth in the sports car segment, with Bangalore alone witnessing a 35 per cent increase
Non-essential services at government & private hospitals disrupted, even private labs keep shutters down
The improvement in adjusted Ebitda was attributed to cost optimisation efforts driven by technology and product enhancements
This drug has shown a 77.20 per cent ulcer closure rate in clinical trials, offering hope for a condition that often leads to severe outcomes like lower limb amputations
Pricing aimed at disrupting market dominated by Royal Enfield
The company further announced plans to incorporate its own cell technology into its vehicles starting from Q1 of FY26
Fischer Medical Ventures is actively looking to expand its portfolio through acquisitions and investments in high-tech medical imaging and technology solutions
The investment will be used to scale production at Kinetic Green's manufacturing facility in Supa, Maharashtra, and to enhance marketing, distribution, and R&D efforts
Mahindra is coming up with Thar Roxx, and plans to reintroduce the iconic BSA Gold Star Bike
Firm's valuation at Rs 40K cr despite tepid response to IPO
Merck Life Science will supply equipment and technologies to Aragen, facilitating a more efficient clinical-to-commercial process timeline
The company claims this test will be priced between Rs 15,000 and 20,000, making it more affordable than the current market options, which range from Rs 30,000 to 40,000
The API business contributed 2 per cent to consolidated revenues, growing 2 per cent Y-o-Y to Rs 141.5 crore
India's current aesthetic medicine market stands at approximately $1.62 billion and is expected to grow at a compound annual growth rate (CAGR) of 13.2 per cent
Company crosses Rs 1,000 crore quarterly revenue mark
For the quarter, the India Branded Business segment saw a 9 per cent growth, reaching Rs 572 crore
As inventory levels have surged to a high of 67-72 days, equating to Rs 73,000 crore worth of stock, the situation is raising alarms about the financial stability and sustainability of dealerships
On a sequential basis, the company exhibited a significant 122.9 per cent increase in PAT, with revenue also increasing by 12.6 per cent
Two Tata Group companies will provide comprehensive solutions that include the purchase of an electric vehicle and the installation of a solar rooftop system